- Home
- NEUP vs TLPH Comparison
NEUP vs TLPH Comparison
Compare NEUP & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- TLPH
- Stock Information
- Founded
- NEUP 1996
- TLPH 2005
- Country
- NEUP United States
- TLPH United States
- Employees
- NEUP N/A
- TLPH N/A
- Industry
- NEUP
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- NEUP
- TLPH Health Care
- Exchange
- NEUP Nasdaq
- TLPH Nasdaq
- Market Cap
- NEUP 12.7M
- TLPH 11.1M
- IPO Year
- NEUP N/A
- TLPH 2011
- Fundamental
- Price
- NEUP $11.89
- TLPH $0.55
- Analyst Decision
- NEUP Strong Buy
- TLPH Strong Buy
- Analyst Count
- NEUP 1
- TLPH 1
- Target Price
- NEUP $21.00
- TLPH $6.00
- AVG Volume (30 Days)
- NEUP 67.0K
- TLPH 3.4M
- Earning Date
- NEUP 08-28-2025
- TLPH 08-14-2025
- Dividend Yield
- NEUP N/A
- TLPH N/A
- EPS Growth
- NEUP N/A
- TLPH N/A
- EPS
- NEUP 0.00
- TLPH N/A
- Revenue
- NEUP $15,662,715.00
- TLPH $27,000.00
- Revenue This Year
- NEUP N/A
- TLPH N/A
- Revenue Next Year
- NEUP N/A
- TLPH $14,533.26
- P/E Ratio
- NEUP $3.84
- TLPH N/A
- Revenue Growth
- NEUP N/A
- TLPH N/A
- 52 Week Low
- NEUP $2.90
- TLPH $0.38
- 52 Week High
- NEUP $126.00
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- NEUP 67.40
- TLPH 65.35
- Support Level
- NEUP $6.82
- TLPH $0.50
- Resistance Level
- NEUP $13.25
- TLPH $0.57
- Average True Range (ATR)
- NEUP 1.32
- TLPH 0.07
- MACD
- NEUP 0.44
- TLPH 0.00
- Stochastic Oscillator
- NEUP 77.78
- TLPH 57.38
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.